Lily Wan

Lily Wan is the Senior Vice President of Business Operations and Corporate Alliance Management at Kriya. Lily joined Kriya from SpringWorks, a company focused on advancing therapies in rare disease and oncology, where she was Director of Program and Alliance Management. She supported development teams to plan and execute on global clinical studies and managed development programs with alliance partners. Prior to SpringWorks, Lily was Senior Director of Program Management at Roivant Sciences where she led planning and organization of drug development projects through NDA preparation and coordination of due diligence reviews for potential in-license assets. She has over 15 years of drug development experience and has held project management roles of increasing responsibility at Aerie, Cempra and Synthon Pharmaceuticals. Lily received her MBA from the University of North Carolina at Chapel Hill and her undergraduate degree in chemical engineering at North Carolina State University.